Renaud Ronald C JR
SEC CIK 1354434 · EDGAR
Most active insiders at KLRA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Kaplan Andrew T. | Dir, 10% | $134.38M | — |
| 2 | BAIN CAPITAL INVESTORS LLC | 10% | $134.38M | — |
| 3 | Bain Capital Life Sciences Investors, LLC | 10% | $25.00M | — |
| 4 | Koppel Adam | Dir, 10% | $25.00M | — |
| 5 | RTW INVESTMENTS, LP | 10% | $8.00M | — |
| 6 | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | 10% | — | — |
| 7 | Renaud Ronald C JR | CEO, Pres, Dir | — | — |
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-11 16:05 | 2026-06-09 | KLRA | Kailera Therapeutics, Inc. | Renaud Ronald C JR | CEO, Pres, Dir | M - OptEx | $5.25 | +38.1K | 38.1K | New | +$200.0K |
| D | 2022-06-27 | 2022-06-23 | ATRA | Atara Biotherapeutics, Inc. | Renaud Ronald C JR | Dir | A - Grant | $0.00 | +20.5K | 31.5K | +186% | $0 |
Purchase Sale Sale after option exercise All abbreviations